Dubai (UrduPoint / Pakistan Point News / WAM – 18 March 2026) The Emirates Pharmaceutical Corporation has confirmed that the drug United Arab EmiratesThe strategic stock of medicines and medical supplies is safe and sufficient to meet local requirements market needs.
Dr. Fatima Al Kaabi, Director General of the Emirates Pharmaceutical Corporation, made field visits to a number of pharmaceutical factories throughout the country. United Arab Emirates As part of the proactive approach and strategic vision followed by EDE to ensure the sustainability of the pharmaceutical ecosystem in the country.
The field visits aimed to support local pharmaceutical manufacturing and review production capabilities and advanced technologies used in drug production.
During the tour, Al Kaabi listened to an explanation from factory officials about the current production capacity, future expansion plans, and advanced manufacturing techniques adopted in line with the highest international standards of quality and safety.
Al-Kaabi reviewed the growing role of local pharmaceutical industries in supporting the stability of national medicine market and enhancing the resilience of pharmaceutical supply chains.
Al-Kaabi said: “ United Arab EmiratesThe pharmaceutical ecosystem is able to respond efficiently to various regional and global developments. The state has succeeded in strengthening the capabilities of local pharmaceutical manufacturers and creating legislative and regulatory frameworks that support the continued growth of this sector.
Dr. Fatima pointed out that local pharmaceutical and medical preparations manufacturers play an essential role in promoting… United Arab EmiratesPharmaceutical security and supporting the national economy, adding that close cooperation with these companies helped ensure that the country’s strategic stock of medicines and medical supplies is safe and sufficient to meet local demand.
Al-Kaabi added: “ United Arab Emirates“The pharmaceutical sector in the UAE is characterized by stability and good readiness, supported by an advanced regulatory system that ensures the continuous availability of medicines to the community in line with the highest standards of quality and safety.”
She stated that the Emirates Pharmaceutical Corporation will spare no effort to create an integrated regulatory environment that supports research and development in the pharmaceutical sector, while developing its regulatory and supervisory policies in line with international standards. The best Practices to maintain the safety, quality and effectiveness of locally manufactured medicines.
The tour conducted by Dr. Fatima Al Kaabi included a number of pharmaceutical manufacturers in the region United Arab Emiratesincluding Medisal Pharma and Adcan Pharma. During the visits, Al Kaabi learned about the production processes, manufacturing processes, and quality and safety assurance systems applied in the various stages of drug production.
Neha Srivastava, Managing Director of Medical Pharma, confirmed that a companyheadquartered in Abu DhabiProud to contribute to United Arab EmiratesPharmaceutical manufacturing ecosystem.
She also praised the role played by the Emirates Pharmaceutical Corporation in supporting the readiness of national pharmaceutical manufacturers and enhancing cooperation with national pharmaceutical companies. industry players.
Srivastava added United Arab Emirates Medisal Pharma is proud of a strong pharmaceutical base supported by an advanced regulatory environment and strong readiness and stability, stressing that Medisal Pharma is committed to ensuring the continued availability of its products in the market. market And prevent shortages in its portfolio to support the country’s drug security system.
Meanwhile, Fukien Sinis, CEO of ADCAN Pharma, said local pharmaceutical manufacturing plays a crucial role in maintaining continued availability of medicines amid increasing global pressures on pharmaceutical supply chains. He reaffirmed a companyIts commitment to providing sufficient supplies to meet them United Arab Emirates market He asks.
Sinis added that Adkan Pharma will continue to work closely with the Emirates Pharmaceutical Corporation to enhance production capabilities and provide high-quality medicines in line with the highest standards of quality and safety.
These visits come within the framework of the efforts of the Emirates Pharmaceutical Corporation to enhance cooperation and integration with the industrial sector, help build an advanced health care system based on innovation, knowledge and sustainability, and enhance United Arab EmiratesIts position as a leading regional country center For the healthcare and pharmaceutical sectors.